؉ T lymphocytes over the course of human immunodeficiency virus type 1 (HIV-1) infection are still incompletely understood, but chronic immune activation is thought to play an important role in disease progression. We studied CD4
CD4
ϩ T cells represent one of the major populations targeted by human immunodeficiency virus type 1 (HIV-1) (17) . Early after the infection of individuals with HIV-1, functional defects of CD4 ϩ T cells (most of them not productively infected at this stage) can be documented. During the progression of the infection to AIDS, a gradual decline of CD4 ϩ T cells is observed; this decline represents the hallmark of the disease and is one of the most clinically relevant parameters.
It has been found that Nef is critically important for virus replication and disease progression in vivo both in HIV-1-infected individuals (14, 33) and in simian immunodeficiency virus (SIV)-infected macaques (32) . Based on numerous observations, Nef appears to play a multifaceted role; it was found to promote high virulence and accelerate viral replication (reviewed in reference 26) and to downregulate cell surface CD4 (47, 61) and major histocompatibility complex class I (MHC-I) (35) molecules, as well as to affect T-cell activation (1, 3, 15, 38, 62) , proliferation (12, 36) , and cytokine (interleukin-2 [IL-2] and IL-10) production (7, 38, 67) . However, numerous controversial findings have been reported. For instance, in some in vitro studies, Nef was found to induce T-cell activation (1, 3, 5, 6, 15, 16, 37, 55, 68) , while in others it was reported to inhibit (2, 3, 11, 13, 20, 30, 38, 45, 46) T-cell activation. Such conflicting results suggest that the function of Nef, particularly in vitro, may be difficult to fully appreciate.
To further study the role of Nef in CD4 ϩ T-cell biology in vivo, we used a murine model of AIDS, CD4C/HIV transgenic (Tg) mice (22, 23) . These Tg mice develop a severe AIDS-like disease, characterized by premature death, wasting, and pathological damage to the kidney (interstitial nephritis and segmental glomerulosclerosis), lung (lymphocytic interstitial pneumonitis), and heart (myocytolysis and myocarditis) (22, 23, 31, 49) . This syndrome occurs without viral replication and is strikingly similar to that observed in AIDS patients, especially pediatric AIDS patients. Previous characterization of these Tg mice also revealed downregulation of cell surface CD4, a loss of thymocytes, and low numbers of peripheral CD4 ϩ T cells but an increase of B cells and their activation (23, 49) . It was also demonstrated that Tg CD4 ϩ T cells fail to upregulate cell surface CD40 ligand (CD40L) upon in vitro stimulation (49) , a phenotype likely to contribute to the failure to generate germinal centers following immunization with ovalbumin (49) .
We used CD4C/HIV Nef Tg mice, which express a single HIV-1 gene, nef, to study the effect of Nef on peripheral Tg CD4 ϩ T cells. Furthermore, since CD4 ϩ T-cell loss and defects are generally considered to account for several of the clinical manifestations of AIDS and to affect prognosis (17) , we examined whether Nef-expressing CD4 ϩ T cells are required for the development and progression of the other AIDS-like organ phenotypes observed in these Tg mice. The present results provide evidence that the expression of Nef alone has a significant impact on CD4 ϩ T-cell division and functions.
MATERIALS AND METHODS
Mice. CD4C/HIV Nef (previously designated CD4C/HIV MutG ) mice, expressing only the nef gene of HIV-1, and CD4C/HIV MutA Tg mice, expressing only the rev, env, and nef genes of HIV-1, have been described previously (23) . The CD4C/HIV Nef Tg mice and their non-Tg littermate controls were used when they were between 6 and 12 weeks of age. The BALB/c mice used to generate the mixed leukocyte reactions (MLR) were 6 to 8 weeks old and were purchased from Harlan Sprague Dawley Inc. The AD10 TcR Tg mice (H-2 k ) (V␣11 and V␤3 specific for pigeon and moth cytochrome c presented by 1-E k ) were provided by Patrice Hugo and were backcrossed with CD4C/HIV Nef Tg mice which had been bred on the B10.BR background for at least seven generations and which were found to be negative for mouse mammary tumor virus types 1 and 6 by genotyping. The CD4-deficient mice were previously described (50) and were originally on a C57BL/6 background. These CD4-deficient mice were backcrossed with CD4C/HIV MutA Tg mice to generate double-mutant mice. Only littermates were compared. All mice used for this work were kept under specificpathogen-free conditions as described previously (59) , and all experiments were approved by the Institutional Animal Ethics Committee.
Antibodies and reagents. The hybridomas producing rat anti-mouse B220 (RA36B2), MHC-II (M5-114), CD8␣ (53-6.72), and hamster anti-mouse CD3ε (145-2C11) monoclonal antibodies (MAb) were purchased from the American Type Culture Collection (ATCC; Rockville, Md.). The hybridoma for hamster anti-mouse CD28 (37.51) was a gift from P. Hugo. The anti-CD3 MAb was purified by using protein G affinity columns. The rabbit anti-Nef polyclonal antibodies were generated as described previously (24) . The fluorescein isothiocyanate (FITC)-and phycoerythrin (PE)-labeled MAb, including anti-CD69, CD44, CD45RB, CD8, B220, hamster immunoglobulin G (IgG), TcR␣␤, TcR␥␦, CD25, CD62L, and 7-amino-actinomycin (7-AAD), were from Cedarlane. The anti-goat IgG-FITC and anti-mouse IgG-PE were from Jackson ImmunoResearch Laboratories Inc. and from Dimension Laboratories Inc., respectively. Irrelevant rat IgG1, rat IgG2a, rat IgG2b, and Armenian hamster IgG1 were used as isotype controls. A Cytofix/Cytoperm Plus kit, a bromodeoxyuridine (BrdU)-FITC flow kit, anti-V␣11 FITC (RR8-1), anti-V␤3 biotin (KJ25), streptavidin allophycocyanin (APC), and anti-CD4 APC were purchased from BD Pharmingen. Phorbol 12-myristate 13-acetate (PMA), ionomycin, DNase, and propidium iodide were from Sigma.
Purification of CD4
؉ T cells. We used two procedures based on negative selection to purify CD4 ϩ T cells from peripheral (axillary, inguinal, cervical, and brachial) lymph nodes (LNs): depletion by using MAb followed by sheep anti-rat immunoglobulin-coated magnetic beads (Dynabeads, Dynal, Oslo, Norway) and cell sorting with a MoFlo cell sorter (Cytomation Inc.). Purification with magnetic beads was performed by preincubation of cells with a cocktail of rat anti-B220 (RA36B2), rat anti-MHC-II (M5-114), and rat anti-CD8 (53-6.72) MAb followed by depletion with sheep anti-rat-coated magnetic beads, as previously described (24) . The purity of the CD4 ϩ TcR␣␤ ϩ /CD8 Ϫ T cells was Ͼ92% for non-Tg mice and ϳ78% for Tg mice as determined by flow cytometry (FACScan/FACS Calibur; Becton Dickinson, San Jose, Calif.).
To obtain purer Tg CD4 ϩ T-cell preparations, cell sorting was used. LN cells were resuspended for 20 min in blocking buffer (phosphate-buffered saline and 20% fetal bovine serum [Gibco/BRL Life Technologies] without sodium azide). Staining was performed with PE-coupled anti-MHC-II, anti-CD8, anti-B220, and anti-TcR␥␦ on ice for 40 min. The CD4 ϩ T cells were sorted by gating on the PE-negative population. The purity of CD4 ϩ TCR␣␤ ϩ cells was 98% in non-Tg mice and 93% in Tg mice, as determined by flow cytometry.
Western blotting. Western immunoblotting for the detection of Nef and of tyrosine phosphorylated proteins was performed as previously described (23, 24) .
Real-time quantitative RT-PCR. The reverse transcription (RT)-PCR assays were performed as follows. For RT, total RNA isolated from ϳ200,000 cells was used as a template in a 20-l reaction mixture containing 1ϫ FIRST-strand buffer as described by the manufacturer (Invitrogen) with Moloney murine leukemia virus reverse transcriptase and 1 mmol of pd(N)6 random primers/liter. After incubation at 42°C for 1.5 h, the enzyme was inactivated at 99°C for 5 min and the product was diluted to 100 l for amplification. Ten microliters was used for quantitative PCR amplification with a Quantitect probe PCR kit (QIAGEN) with a reaction mixture containing 200 nM primers, 100 nM probe, 3 mM MgCl 2 , 800 M deoxynucleoside triphosphates, 1.25 U of Immolase polymerase (Bioline), and 50 mM ROX dye passive control. Quantitative PCR was performed with an MX4000 multiplex quantitative PCR instrument (Stratagene). Amplification was performed with a reaction volume of 50 l for 40 cycles (30 s at 95°C, 1 min at 60°C). The primers and fluorescent probes used were specific for a 150-to 300-bp amplicon of fully spliced HIV-1 transcripts and a 100-bp amplicon of the S16 as internal standard. Primers and probes were designed and synthesized by Integrated DNA Technologies, Inc., as follows: for HIV (strain NL4-3), for1 (CGC GCA CGG CAA GA), rev1 (GAT CGT CCC AGA TAA GTG CTA AGG), and probe 1/56-FAM-ACC CGA CAG GCC CGA AGG AAT AGA AGA-3BHQ-1; for S16, for (CTT CTG GGC AAG GAG CGA TTT), rev (GAC TGT CGG ATG GCA TAA ATT TGG), and probe 5HEX-CCA CCA CCC TTC ACA CGG ACC CGA-3BHQ-1. The specificity, sensitivity, and reproducibility of the quantitative PCR assays were verified by using cDNA prepared from the thymuses of Tg mice expressing HIV-1 (23) . CFSE fluorescent-dye cell labeling and division assay. CFSE (5-and 6-carboxy-fluorescein diacetate succinimidyl ester) (Molecular Probes Inc.) labeling was performed as previously described (24) . Anti-CD3 (5 g/ml) coated onto plastic dishes, soluble anti-CD28, recombinant mouse IL-2 (100 U/ml; Roche Diagnostics GmbH), PMA (5 ng/ml), and ionomycin (250 ng/ml) were used to stimulate CD4 ϩ T cells. Unstimulated cells were used as a fluorescence baseline control. CSFE-labeled cells were analyzed by flow cytometry as described below.
Allogeneic MLR. CD4 ϩ T cells (10 5 ) purified from peripheral LNs of CD4C/ HIV-1
Nef Tg mice or non-Tg littermates were cocultured with 10 6 irradiated (3,000 rads) BALB/c splenocytes in round-bottom 96-well plates in complete medium (Iscove's modified Dulbecco medium supplemented with 5% fetal bovine serum, 2-mercaptoethanol, and antibiotics). After 48 h, the cells were labeled for 16 h with 1 Ci of [ 3 H]thymidine/well and then harvested onto glass fiber filters. Incorporated radioactivity was measured with a scintillation counter (RackbetaII-LKB).
Measurement of in vivo DNA synthesis by BrdU incorporation. BrdU (Sigma) (0.8 mg/ml) was added to drinking water daily for 7, 14, or 21 days. The peripheral LNs were then collected, and CD4
ϩ T-cells were purified with Dynabeads. The CD4 ϩ T cells were fixed and permeabilized with reagents from the BrdU flow kit (BD Pharmingen) according to the manufacturer's instructions. To expose incorporated BrdU, the DNA was digested with 30 g of DNase (Sigma)/ well for 1 h at 37°C. After staining with FITC-conjugated anti-BrdU antibody, 20,000 events were acquired by using a FACS Calibur flow cytometer. Data were analyzed with CellQuest software by following the BD protocol.
Flow cytometric analysis. Immunostaining was performed as described previously (23, 24) . FACScan and FACS Calibur flow cytometers and Cellquest software (Becton Dickinson) were used for Flow cytometric analyses.
Statistics. Statistical analyses (analysis of variance, Sigmastat, and Student's t test) were performed as previously described (24) except that for data presented in Fig. 6 , the Student t tests were performed with the Bonferroni correction for multiplicity of tests. For comparison of the distribution of cells in different categories, i.e., cells having reached one, two, three, four, five, or six divisions in the Tg and non-Tg groups, the Pearson chi-square test was used.
RESULTS

Low recovery of and Tg expression in purified peripheral CD4
؉ T cells. Peripheral CD4 ϩ T-cell numbers were previously found to be preferentially decreased in CD4C/HIV-1 Tg mice, as determined by fluorescence-activated cell sorter (FACS) analysis (22, 23) . For the present study, Tg and non-Tg peripheral LN CD4 ϩ T cells were obtained by negative selection by using cell sorting or magnetic beads. A decrease in absolute numbers of recovered Tg CD4 ϩ T cells relative to those of recovered non-Tg CD4 ϩ T cells was observed. As much as a 10-fold reduction in recovered peripheral CD4 ϩ T cells (CD4 ϩ , TcR␣␤ ϩ ) was documented in 1.5-to 3-month-old Tg mice from two distinct Nef-expressing lines (CD4C/ HIV MutA and CD4C/HIV Nef ) (9.5 ϫ 10 6 CD4 ϩ T cells were recovered from 22 non-Tg mice, 1.1 ϫ 10 6 CD4 ϩ T cells were recovered from 18 CD4C/HIV MutA mice, and 1.5 ϫ 10 6 CD4 ϩ T cells were recovered from 36 CD4C/HIV Nef mice; P Ͻ 0.001, Student's t test).
Since Nef is the major determinant of disease in CD4C/HIV Tg mice (23), we assessed the expression of Nef protein in Tg CD4 ϩ T cells. Western blot analysis with anti-Nef polyclonal antibody revealed high levels of expression of Nef in lysates of these cells (Fig. 1A) . This result suggests that the low number and some of the anomalies of peripheral CD4
؉ T cells seen in these mice may be related to the expression of Nef in these cells.
Peripheral Tg CD4 ؉ T cells exhibit an activated/memorylike phenotype. To determine the cell surface phenotype of the Tg peripheral CD4 ϩ T cells, labeling with different antibodies and FACS analysis were performed with purified LN CD4 ϩ T cells. Often, two subpopulations, CD4
ϩhigh and CD4 ϩlow , were clearly identifiable in Tg mice, while only a CD4 ϩhigh population was present in non-Tg mice ( Fig. 2A) . The CD4 ϩlow cells expressed higher levels of HIV-1 RNA than the CD4 ϩhigh cells, as was expected on the basis of the degree of CD4 downregulation (Fig. 1B) Fig. 2C .
To investigate whether antigenic stimulation (most likely by environmental antigens) through the T-cell receptor (TCR) was required for the appearance of the activated/memory-like phenotype of Tg CD4 ϩ T cells, we bred the CD4C/HIV Nef Tg mice with the AD10 TcR Tg mice. The latter Tg mice harbor a TCR transgene (comprising V␣11 and V␤3 chains) which is expressed at high levels on the majority of peripheral CD4 ϩ T cells and which is specific for pigeon or moth cytochrome c. Since these antigens are not normally present in mice, the vast majority of V␣11 Hi and V␤3 Hi cells represent naïve cells. Analysis of LN cells from the CD4C/HIV Nef ϫ AD10 double-Tg mice revealed a large relative decrease of V␣11 Hi CD4 ϩ T cells and a relative increase of V␣11 low/negative CD4 ϩ and V␣11 low/negative CD4 Ϫ T cells compared to the number of cells for AD10 single-Tg mice (Fig. 3A) . These V␣11 low/negative T cells may express endogenously rearranged TCR chains, and their origin is under investigation (P. Chrobak and P. Jolicoeur, unpublished data). Therefore, in order to exclude such cells, we further analyzed only CD4 ϩ T cells expressing high levels of the TCR transgene. In CD4/HIV Nef ϫ AD10 double-Tg mice, activation markers (CD44, CD69, and CD25) were expressed on a higher proportion of V␣11 Hi CD4 ϩ T cells of the LNs (Fig. 3 ) and the spleen (data not shown) compared to AD10 single-Tg controls, thus showing an activated/memo- Tg and Tg CD4 high cells were compared, as were groups of non-Tg and Tg CD4 low T cells. For each of the three experiments performed, the percentage of Tg CD4 ϩ T cells expressing M2 and M1 was statistically different (P Ͻ 0.001) from the percentage of non-Tg CD4 ϩ T cells doing so. In addition, pooled data from the three experiments (shown in panel C) were analyzed by Student's t test. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01; ‫,ءءء‬ P Ͻ 0.001.
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ry-like phenotype. This phenotype appeared predominantly in CD4 ϩlow Tg T cells (Fig. 3A) . Importantly, the activated phenotype observed in V␣11 Hi CD4 ϩ T cells from double-Tg mice was not decreased compared to that in CD4C/HIV Nef single-Tg mice, as might have been anticipated if antigenic stimulation played a role in this phenotype. A summary of these experiments is shown in Fig. 3B ). These results suggest that environmental antigenic stimulation may not be required for generating this phenotype.
Thymocytes from CD4C/HIV Nef Tg mice were previously found to be in a state of activation and to be hyperresponsive to anti-CD3 stimulation, as assessed ex vivo by measurement of their tyrosine phosphorylation pattern (23) 
ϩ T cells than in non-Tg CD4 ϩ T cells (Fig. 4) . ϩ T cells was associated with an increase in T-cell proliferation, we assessed cell proliferation in vivo following labeling with BrdU provided in drinking water for 7 (data not shown), 14, or 21 days (Fig. 5) . Measurement of cells which had synthesized DNA (BrdU-positive cells) was performed by FACS with purified sorted CD4 ϩ T cells (Fig.  5A) . A summary of the results from four experiments is shown in Fig. 5B . The proportion of BrdU-positive Tg CD4 ϩ T cells was found to be increased approximately threefold compared to that of non-Tg CD4 ϩ T cells (Fig. 5B) , indicating a higher proportion of Tg CD4 ϩ T cells initiating DNA synthesis. In addition, a higher proportion of Tg CD4 ϩ T cells than of non-Tg CD4 ϩ Tg cells was found to be in the S phase by measurement of the cell cycle by propidium iodide staining of the total DNA content (data not shown). Together, these results suggest an enhanced in vivo division of peripheral CD4 ϩ T cells expressing Nef.
Tg peripheral CD4 ؉ T cells show reduced cell division capacity upon stimulation in vitro. To determine the proliferative capacity of Tg CD4 ϩ T cells in vitro, sorted CD4 ϩ T cells were labeled with CFSE and analyzed by FACS following different stimulations. This analysis showed that upon in vitro stimulation with a combination of anti-CD3 and anti-CD28 MAb, the majority of non-Tg CD4 ϩ and Tg CD4 ϩhigh T cells divided three to five times (M4 to M6) over a 3-day period, while most Tg CD4 ϩlow T cells underwent fewer (two to four) divisions (M3 to M5) (Fig. 6A) . The percentage of Tg CD4 ϩlow T cells which underwent four divisions or more (M5 and M6) (8%) was lower than that of the non-Tg CD4 ϩ T cells that did (39%). In addition, significant populations of live (7-AADnegative) Tg CD4 ϩhigh (21%) and Tg CD4 ϩlow (ϳ30%) T cells did not divide at all (M1) or underwent only one division (M2), whereas such cells were rare (7%) in non-Tg mice. A summary of several experiments is shown in Fig. 6B . Very similar results were obtained with CD4 ϩ T cells purified with magnetic beads (data not shown). (Fig. 6B) , indicating that IL-2 could not rescue this phenotype. After stimulation with PMA plus ionomycin, a population of Tg CD4 ϩ Tg cells still failed to proliferate, but most of these cells proliferated as well as non-Tg CD4 ϩ T cells (Fig.  6B) . However, after stimulation with anti-CD3 MAb plus PMA, comparable proliferation of Tg and non-Tg CD4 ϩ T cells was observed (Fig. 6B) . These results suggest that PMA may bypass the inhibitory effect of Nef on cell division.
Therefore, in response to various stimuli, the peripheral Tg CD4 ϩ T cells present in vitro cell autonomous alteration(s) of TcR signaling or distal to it but proximal to the PMA pathway, which cannot be overcome completely by IL-2. The fact that the more severe phenotype is observed in Tg CD4 ϩlow T cells, which express higher levels of Nef, suggests that this phenotype correlates with the level of Nef expression.
Hyporesponsiveness of peripheral Tg CD4 ؉ T cells in allogeneic MLR. The response of Tg CD4
؉ T cells to in vitro stimulation was assessed with an additional functional assay, the MLR assay. Irradiated total splenocytes from normal BALB/c (H-2 d ) mice were used as stimulators to induce the proliferation of purified allogeneic CD4 ؉ T cells from Tg and non-Tg C3H (H-2 k ) mice. Tg CD4 ؉ T cells were found to be impaired in their proliferative capacity to respond to an allogeneic MHC stimulation (Fig. 7) , again suggesting a functional alteration of these cells. Similar results were obtained with CD4 ϩ T cells purified by cell sorting or with Dynabeads.
The increased cell death following in vitro stimulation of peripheral Tg CD4
؉ T cells occurs after limited cell divisions.
Given that the Tg CD4
ϩ T cells show limited cell division after in vitro stimulation, we investigated whether this phenotype was associated with enhanced cell death. Non-Tg and Tg sorted CD4 ϩ T cells (Ͼ95% 7-AAD negative at time zero) were labeled with CFSE and stimulated with a combination of anti-CD3 and anti-CD28 MAb for 3 days. Apoptotic or dead cells (gated on the 7-AAD-positive population) were analyzed for their CFSE patterns. A high proportion (30 to 49%) of Tg CD4 ϩlow T cells were found to undergo apoptosis or death after very limited cell division (zero or one division; M1 and M2), while most non-Tg CD4 ϩ T cells and Tg CD4 ϩhigh cells died after three to five divisions (M4 to M6) ( Fig. 8A and B) . Similar results were obtained after other stimulations with anti-CD3 plus IL-2 and PMA plus Iono (Fig. 8B) . However, no significant difference was observed between CD4 ϩ T cells from non-Tg mice and those from Tg mice after stimulation with anti-CD3 plus PMA (Fig. 8B) . Therefore, these results demonstrate that, in vitro, the Tg CD4 ϩ T cells have a significantly compromised cell division capacity that is associated with cell death. CD4 ؉ T cells are dispensable for the development of the AIDS-like organ disease in CD4C/HIV Tg mice. In an attempt to clarify whether or not the defects of peripheral Tg CD4 ϩ T cells contribute to the development of the other phenotypes related to AIDS observed in the CD4C/HIV Tg mice, we used a genetic approach to delete the CD4 ϩ T-cell population from these mice. The CD4C/HIV MutA Tg mice were used for these experiments. These mice express only the rev, env, and nef Ϫ/Ϫ or CD4 ϩ/Ϫ non-Tg mice. These mice were observed for up to 12 months. No significant difference in mortality rates was found between CD4 ϩ/Ϫ and CD4 Ϫ/Ϫ CD4/ HIV MutA Tg mice (Fig. 9A) . Indeed, the CD4 Ϫ/Ϫ CD4C/ HIV MutA Tg mice developed severe AIDS-like pathological changes, such as wasting, atrophy of lymphoid tissues, and lymphocytic interstitial pneumonitis and interstitial nephritis, which were indistinguishable from those observed in the control CD4 ϩ/Ϫ CD4C/HIV MutA Tg mice (Fig. 9B) or from those reported for CD4 ϩ/ϩ CD4C/HIV Tg mice (22, 23) . The nonTg littermate controls (either CD4 Ϫ/Ϫ or CD4 ϩ/Ϫ ) did not develop any novel pathological lesions during these experiments (data not shown), confirming that the appearance of lesions was transgene-specific. Immunophenotyping of LN cells revealed the same pattern of staining with various MAb (TcR␣␤, CD8, and B220) for cells from CD4 Ϫ/Ϫ CD4C/HIV Tg as well as CD4 ϩ/Ϫ CD4C/HIV Tg mice ( Fig. 9C and Table 1).
Although the immune compartments of the CD4 Ϫ/Ϫ CD4C/ HIV MutA Tg mice remain to be analyzed, our findings indicate that the functionally impaired Tg CD4 ϩ T cells, expressing the HIV gene products, are unexpectedly dispensable for the development and progression of many of the severe AIDS-like organ phenotypes observed in these Tg mice.
DISCUSSION
The CD4
؉ T cells of CD4C/HIV Nef Tg mice present an activated/memory-like phenotype and show enhanced in vivo division. The present study, which was focused on understanding the impact of Nef on the phenotype and function of peripheral CD4 ϩ T cells in CD4C/HIV Tg mice, revealed a constitutive state of tyrosine hyperphosphorylation which was increased after the engagement of CD3/TcR, indicating an activated molecular phenotype. These results were similar to those obtained previously with thymocytes from these Tg mice (23) . In addition, immunophenotyping of these Tg CD4 ϩ T cells showed that a larger proportion of them than of non-Tg cells were CD44 high , CD45RB low , and CD62L low cells and expressed CD69 and CD25. This activated/memory-like phenotype (63) was more apparent in the Tg CD4 ϩlow than in the Tg CD4 ϩhigh T-cell subpopulations; the Tg CD4 ϩlow T cells expressed higher levels of Nef and, as a consequence, showed a more severe downregulation of the CD4 cell surface molecule. Similar enhanced expression of CD44 and lower expression of CD62L on Nef-expressing CD4 ϩ T cells from other Nef Tg mice have been reported (36) . Also, some previous reports have shown increased in vitro T-cell activation (16, 40, 60) (enhanced expression of CD69 and CD25 [3] and IL-2 production [52, 54, 55, 67, 70] ) in HIV-1 or SIV (1, 15, 37) Nefexpressing CD4 ϩ T cells (reviewed in references 25 and 51). However, other results showed that Nef did not affect CD69 or CD25 expression (9, 30, 54, 56, 67) and was in fact blocking proximal signal required for CD69 expression (30) and inhibiting activation pathways (2, 11, 20, 21) in vitro. These contrasting in vitro results most likely reflect the T cells used for experimentation by different groups and may not be comparable to the data obtained here with the Tg CD4 ϩ T cells. Consistent with the behavior of the cells in their activated state, we found that the proportion of Tg CD4 ϩ T cells entering the S phase in vivo was also larger than that of non-Tg CD4 ϩ T cells doing so. This finding most likely reflects a higher rate of division rather than slower rate of death, since these peripheral CD4 ϩ T cells also show enhanced apoptosis compared to non-Tg cells, as assessed by labeling with annexin V ϩ T-cell division in HIV-1-infected individuals has been provided, although not by all groups (27, 28, 41, 69) . However, since the above studies did not distinguish between infected and noninfected CD4 ϩ T cells and since the majority of human CD4 ϩ T cells are not infected in vivo, the molecular basis for enhanced cell division of human (largely uninfected) CD4
ϩ T cells and Tg mouse (largely Nef-expressing) CD4
ϩ T cells may not be the same.
It is not clear how Nef is involved in this chronic activation of CD4 ϩ T cells in vivo. Our results with the double-Tg (CD4C/HIV Nef ϫ AD10 TcR) mice, which did not present a decrease in the activated phenotype of CD4 ϩ V␣11 High T cells, suggest that the upregulation of activation markers might be independent of stimulation by antigens through the TCR. However, the possibility of stimulation by antigens through endogenous TcR␣␤ rearranged chains cannot be completely excluded, since these mice were not bred on a Rag-deficient background, but appears unlikely. Nef could directly activate the CD4 ϩ T cells in which it is expressed. It has been shown that Nef expression can activate the proximal TCR machinery (25, 51) , allowing hyperphosphorylation of effectors such as LAT (23), which has been implicated in T-cell activation (71) . On the other hand, the expansion of an activated Tg CD4 ϩ T-cell subset may represent a physiological response to the disease process. Antigen-dependent and -independent activation of T cells undergoing regenerative expansion in lymphopenic hosts has been described (10, 19, 43 ; for reviews, see references 39 and 64), including in HIV-1 infected individuals (66) . In addition, the production of activated/memory-like Tg CD4 ϩ T cells with low CD4 expression may be a consequence of altered thymic maturation; Nef is indeed already expressed at the DP thymocyte stage, and CD4 ϩ SP thymocytes are CD4 low and a higher percentage of them than of non-Tg controls express CD25 (P. Chrobak and P. Jolicoeur, unpublished data). However, the downregulation of CD4 is also likely caused by mechanisms other than altered selection, since it is present on TcR neg/low CD4 ϩ CD8 ϩ DP thymocytes, which have not undergone selection yet. Finally, the Tg CD4 ϩ T cells with the activated phenotype may even represent a subpopulation of regulatory T cells which often express some activation markers, namely, CD25 (18) (see below).
The induction of such an activated state of the CD4 ϩ T cells, one of the major target cell populations of the virus, may provide an advantage for its replication. Indeed, the expression of the HIV-1 genome in CD4 ϩ T cells has been shown to be dependent on the state of activation of the infected cells, and the integrated proviral DNA is not substantially expressed until cellular activation occurs (8) .
The present results with the CD4C/HIV Tg model, which reflects human AIDS for a large number of phenotypes, raise the possibility that Nef may favor the development of a similar activated phenotype of HIV-1-infected human CD4 ϩ T cells in vivo.
Impaired in vitro proliferation of CD4 ؉ T cells from CD4C/ HIV Nef Tg mice. In contrast to their enhanced in vivo division, the Tg CD4 ϩ T cells were found to have a very limited proliferative capacity in response to in vitro stimulation. These impaired in vitro responses add to the low helper functions measured previously in the CD4C/HIV Tg mice, which were reflected by low CD40L expression, impaired germinal-center formation, and reduced immunoglobulin isotype class switching (49) .
Similar low in vitro proliferation of CD4 ϩ T cells was previously observed with human cells from HIV-1-infected individuals (4, 29, 34, 42, 53, 58) . However, a large proportion of these human CD4 ϩ T cells are not infected and their phenotype is influenced by indirect factors; the molecular basis for their phenotype may be distinct from the Nef-induced proliferation defects observed in the CD4C/HIV Nef Tg mice. Impaired in vitro proliferative responses, however, have not been reported in most studies with HIV-1-or SIV-infected or Nefexpressing CD4 ϩ T cells, possibly because transformed cell lines or in vitro-infected cultured, stimulated CD4 ϩ T cells obtained from peripheral blood mononuclear cells were used for experimentation. Impaired in vitro proliferative responses were, however, observed in ConA-or SEB-stimulated total spleen or LN cells from other Nef Tg (B6/338L) mice (36) and in Jurkat T cells expressing an inducible SIV Nef (44) .
The molecular mechanisms of the in vitro defects of CD4C/ HIV Tg CD4 ϩ T cells are likely to be complex. Downregulation of the CD4 molecule on the cell surface is unlikely to be the unique cause of the proliferative defects, since a myristoylation-negative mutant of Nef expressed in Tg mice under the same CD4C regulatory sequences does not induce disease or inhibit T-cell proliferation but nevertheless still induces downregulation of CD4, although this downregulation is less extensive (an ϳ30 to 50% decrease of mean fluorescence intensity) than that seen with the wild-type Nef (an ϳ60 to 70% decrease) (49) (Z. Hanna, E. Priceputu, D. G. Kay, J. Poudrier, P. Chrobak, and P. Jolicoeur, unpublished data). First, these in vitro proliferation defects may be directly induced by intracellular Nef proteins, since they correlate with the levels of Nef expression. Our data suggest the existence of a major alteration of signal transduction following the engagement of CD3/ TcR in these Tg mice. This alteration appears to be at the level of or distal to the TCR itself and upstream of protein kinase C. Second, the in vitro proliferation defects of these CD4 ϩ T cells may reflect their in vivo history in a disturbed environment of enhanced division, which makes them unresponsive to further in vitro stimulation. In fact, a similar phenotype of chronic activation and expansion of effector-memory T cells in vivo with a decreased ability for clonal expansion in vitro has been described in CD70 Tg mice (65) . This chronic activation state was found to be associated with the development of a lethal immunodeficiency with losses of thymocytes and of peripheral CD3 ϩ T cells. Similarly, the chronic activation of CD4 ϩ T cells in CD4C/HIV Tg mice may contribute to the thymic atrophy and the very low numbers of peripheral CD4 ϩ T cells previously observed in these Tg mice (22, 23) , which has been confirmed here by direct purification techniques. However, our breeding experiments with a CD4-deficient background indicate that these activated Tg CD4
ϩ T cells are not required for the development of several AIDS-like organ phenotypes that were present in the mice. (premature death, wasting, interstitial nephritis and segmental glomerulosclerosis, lymphocytic interstitial pneumonitis [22, 23] , and cardiomyopathy [31] ). Finally, the activated phenotype of Tg CD4 ϩ T cells, their reduced expression of CD40L, and their increased production of gamma interferon (49) , as well as their hyporesponsiveness in an MLR or after stimulation with MAb engaging the TCR, raise the possibility that a population of professional regulatory/suppressor T cells (57) might be preferentially selected and/or expanded in these CD4C/HIV-1 Nef Tg mice. Immature dendritic cells are thought to play an important role in inducing these regulatory suppressor CD4 ϩ T-cell subsets (57). Moreover, dendritic cells from these CD4C/HIV-1 Tg mice were found to have an immature phenotype and to be functionally impaired as disease progresses (48) . 
